ALB and Duchenne muscular dystrophy: Difficult to resolve in the context of our positive histopathology data, though, is that DMF could not abrogate clinically relevant hematologic biomarkers of DMD (e.g., CK or oxidized albumin) or improve force output of SOL despite conferring significant sarcolemma protection to this muscle (Figure 6, F–J).